Previous successful internship proposals

Institute for Clinical Evaluative Sciences

2017 - Examining disparities in adherence to cervical cancer screening in Ontario: An application of multistate transitional models

London Health Sciences Centre

2010 to 2016 - The prostate cancer risk stratification (ProCaRS) database project – impact of androgen ablation and radiation dose

2010 to 2016 - MRS/US prostate cancer biopsy data analysis

Ontario Clinical Oncology Group

2019 - Comparing laparoscopic and open hepatectomy for colorectal cancer with liver metastases at a population level

Canadian Clinical Trials Group, previously known as National Cancer Institute of Canada (NCIC) Clinical Trials Group

2018 - Identify drug resistance gene mutation pathway for breast cancer patients

2017 - SAS Statistical toolbox for biomarker analysis with cancer clinical trials data

2010 to 2016 - Inference problems after biomarker-guided subpopulation selection in clinical trials

2010 to 2016 - Multi-marker model in cancer clinical trials

2010 to 2016 - Statistical models for pre-post-treatment biomarkers correlation to patients’ outcomes

2010 to 2016 - Pharmacogenetic analysis of NCIC Clinical Trials Group BR.24 study: genome wide association study (GWAS), post GWAS, and pathway analyses: a combined Queens-OCI-OICR collaboration

2010 to 2016 - Statistical analysis for several projects related to NCIC Clinical Trials Group LY.12 trial

Lunenfeld-Tanenbaum Research Institute

2018 - Evaluation of screening efficiency by colonoscopy in Lynch Syndrome and Familial Colorectal Cancer Type X families

Ontario Clinical Oncology Group

2019 - Comparing laparoscopic and open hepatectomy for colorectal cancer with liver metastases at a population level

Ontario Institute for Cancer Research

2020 - Developing pre-cancer prediction models using epigenetic factors from circulating tumour DNA

2020 - Integrative multi-omics analysis of multiple cancer types for biomarker discovery and functional interpretation

2019 - Developing blood-based biomarkers from circulating tumour DNA for early cancer diagnosis

2019 - Predicting cancer risk from genome-wide association studies using pathway and network analysis

2018 - The impact of ARCH on blood-based cancer and CVD development

2017 - Discovery and interpretation of network-associated driver mutations in cancer genes and pathways

2010 to 2016 - A statistical framework for interpreting non-coding cancer mutations in gene regulatory networks

2010 to 2016 - Integrated prognostic mRNA and miRNA signatures for cervix cancer outcome

2010 to 2016 - Statistical models to exploit the clinical importance of rare genetic variants in cancer

Ottawa Hospital Research Institute

2010 to 2016 - Pragmatic trials to enhance the care of breast cancer patients

Princess Margaret Cancer Centre

2020 - Prediction of toxicity after pelvic radiotherapy

2020 - Genetic polymorphisms and clinical risk factors on head and neck cancer survival and toxicity outcomes

2019 - Mediation analysis methods for translational research on causal pathways

2019 - Genetic polymorphisms and clinical risk factors on head and neck cancer survival and toxicity outcomes

2018 - Genetic polymorphisms and head and neck cancer outcomes

2010 to 2016 - Genetic polymorphisms and head and neck cancer outcomes 

2010 to 2016 - Methodological approaches for an integrated translational pharmacogenomic research in esophageal cancer: from pre-clinical mouse models to genome wide association studies and combined biostatistical-bioinformatic approaches

2010 to 2016 - A genetic signature on arrayCGH data

2010 to 2016 - Biomarker signature detection in NCIC BR10 lung cancer trial

2010 to 2016 - Finding biomedical markers in lung and cervix cancer

2010 to 2016 - Tumour microenvironment and targeted treatment